NICE calls for increased use of magnesium sulfate in preterm labour

NICE | Published online: 19 October 2016

Image source: NICE

The new quality standard highlights the key areas where preterm labour and birth services need to improve.

Studies show the risk of cerebral palsy in babies is significantly lower when women who may give birth early are treated with magnesium sulfate, which can protect developing babies’ brains.

The standard also calls for women who have previously lost a baby mid-trimester or had a previous preterm birth to be offered treatment to prevent the cervix opening early to delay labour and birth.

Professor Gillian Leng, deputy chief executive of NICE, said:

“We know the risks of long-term developmental problems are greater the earlier a baby is born. This quality standard highlights key issues, originally raised in the NICE guideline on Preterm labour and birth, where care needs to improve. For instance the quality standard calls for greater use of magnesium sulfate in women at risk of a preterm birth, which we know has significant potential to reduce disability among babies born preterm.”

The guidance also recommends certain pregnant women are offered maternal corticosteroids, which help with babies’ lung development.

Read the overview here

Read the full guidance here


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s